Trials / Sponsors / Partner Therapeutics, Inc.
Partner Therapeutics, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Sargramostim With Ipilimumab Containing Therapy in Patients With Solid Tumors Solid Tumor, Solid Tumor, Adult | Phase 2 | 2024-01-01 |
| Completed | Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety of Sargramostim Administered Subcutaneously, Drug Kinetics, Drug Effects on Physiology | Phase 1 | 2022-04-13 |
| Completed | Sargramostim Use in COVID-19 to Recover Patient Health Covid19, SARS-CoV Infection | Phase 2 | 2021-04-27 |
| Completed | Study of Sargramostim in Patients With COVID-19 COVID-19, SARS-CoV-2 | Phase 2 | 2020-08-18 |
| Active Not Recruiting | A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) Solid Tumours Harboring NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion | Phase 2 | 2015-01-01 |